J B CHEMICALS AND PHARMA
JBCHEPHARM · NSE · inactive
2,408.90
-97.10 (-3.87%)
as of 16 Jul 2026 close
Open
2,506.00
High
2,525.50
Low
2,380.00
Prev close
2,506.00
52w high
2,525.50
16 Jul 2026
52w low
1,638.50
26 Sept 2025
VWAP
2,418.56
Delivery %
66.8%
of volume
Volume 47.79 L · turnover ₹1155.88 Cr · NSE bhavcopy (official close), adjusted for splits/bonuses · history since 02 Feb 1995
- Series
- EQ
- F&O
- No
- Status
- Inactive since 17 Jul 2026
Source: NSE equity master · as of 16 Jul 2026
Market cap
—
P/B
—
ROE (TTM)
17.1%
ROCE 23.0%
Debt / equity
0.00
P/E (TTM)
—
P/S (TTM)
—
Revenue TTM
₹4,148 cr
Net profit TTM
₹709 cr
Net margin TTM
17.1%
OPM 26.0%
EV / EBITDA
—
Interest cover
172.0×
Revenue growth
-4.8%
latest quarter YoY
Profit growth
-30.4%
latest quarter YoY
Dividend yield
—
₹22 / share · payout —
Consolidated · last four quarters to 2026-03-31 · balance sheet 2026-03-31 · tap a tile for the formula
Daily · NSE EOD
Annual reports · 0
Source: NSE
No annual reports filed on NSE yet.
Investor presentations · 28
- 16 Jan 2026JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Investor Presentation ↗2.52 MB
- 11 Nov 2025JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Investor Presentation ↗2.54 MB
- 30 Jul 2025JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Investor Presentation ↗2.20 MB
- 30 Jun 2025JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Investor Presentation ↗1.65 MB
- 14 May 2025JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Investor Presentation ↗-
- 04 Feb 2025JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Investor Presentation ↗-
- 07 Nov 2024JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Investor Presentation ↗-
- 08 Aug 2024JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Investor Presentation ↗-
- 17 May 2024JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Investor Presentation ↗-
- 06 Feb 2024JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Investor Presentation ↗-
- 19 Dec 2023JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Investor Presentation ↗-
- 07 Nov 2023JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Investor Presentation ↗-
- 09 Aug 2023JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Investor Presentation ↗-
- 24 May 2023JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Investor Presentation ↗-
- 08 Feb 2023JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Investor Presentation ↗-
- 10 Jan 2023JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Investor Presentation ↗-
- 11 Nov 2022J. B. Chemicals & Pharmaceuticals Limited has informed the Exchange about Investor Presentation ↗-
- 04 Aug 2022J. B. Chemicals & Pharmaceuticals Limited has informed the Exchange about Investor Presentation ↗-
- 27 May 2022Investor Presentation on financial results for the quarter and year ended on March 31, 2022 ↗-
- 14 Feb 2022JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Investor Presentation ↗-
- 11 Nov 2021JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Investor Presentation ↗-
- 12 Aug 2021JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Investor Presentation ↗-
- 14 Jun 2021JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Investor Presentation ↗-
- 10 Feb 2021JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Investor Presentation ↗-
- 10 Nov 2020JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Investor Presentation ↗-
- 25 Jun 2020JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Investor Presentation ↗-
- 04 Feb 2020JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Investor Presentation ↗-
- 04 Feb 2020JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Investor Presentation ↗-
Credit ratings · 0
No credit-rating announcements filed.